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A stereocontrolled total synthesis of the vitamin D2metabolite
1a,25-dihydroxyergocalciferol (1), which involves a coupling of
the previously described A ring synthon 2 with the appropriately
functionalized C-D moiety 3, is described. In the key step, stereo-
chemical control is achieved by taking advantage of the thermal
reversibility of a [3+ 2]-cyc1oaddition of methyl 0,~-dimethyl-
acrylate and the C-D C-23 nitrone 4 to effect conversion to the
C-24S isoxazolidinecarboxylic acid methyl ester Sa, which is readily
transformed by reduction followed by elimination of the nitrone
function into the necessary C-D precursor.
The discovery of the importance of metabolism in the activation of vitamin
D3t..2has stimulated a renaissance of research in this area. While it is well
known that the vitamin Dendocrine system controls calcium absorption,
serum levels of calcium and phosphorus, and bone resorption and mineralizat-
ion, the precise roles of the various metabolites have yet to be uncovered. Since
the naturally occurring metabolites can be isolated only in extremely minute
amounts, considerable interest in their synthesis, as well as in preparing new
analogs, has been generated.
While it is believed that vitamin D2 (ergocalciferol) metabolism! parallels
that of vitamin D3 (cholecalciferol), little is known about the biological activity
of the various metabolites in man. We undertook the synthesis of 1a,25-dihy-
droxyergocalciferol" in order to make the substance available for biological
studies, being particularly interested in uncovering any therapeutic utility.
The use of a convergent total synthesis as the method of choice for
preparing the 1a-hydroxylated vitamin D derivatives and analogs has already
been well demonstrated in the synthesis of 1a,25-dihydroxycholecalciferol4,
1a,25S,26-trihydroxycholecalciferoP, and calcitriol lactone", as well as several
other derivatives and analogs.
Thus, total synthesis (Scheme 1) of 1a,25-dihydroxyergocalciferol (1)
requires the preparation of the suitably protected C-D synthon 3 for coupling
with the anion of the 1a-hydroxylated A ring synthon 2 (Scheme 1). Since 2
was already on hand+, major synthetic efforts were directed at the ketone 3.
The side chain (commencing at C-20) bears five contiguously functionalized
* Dedicated to Professor Mihailo Lj, Mihailović on the occasion of his 60th
birthday.








3 a R':= H





carbon atoms with the chiral centers in a 1,4-relationship. It was our intention
to generate the remote C-24 chiral center by chiral induction und er the
influence of the pre-existing asymmetry at C-20. The approach to this side
chain was patterned after our successful stereocontrolled total synthesis of
1u,25S,26-trihydroxycholecalcifero15• The key step in that synthesis was the
[3+ 2]-cyc1oaddition of the C-23 nitrone 4 and methyl methacrylate to pro-
duce the 23S,25S isomer 11 with effective control of the stereochemistry at

















Consequently, in a retrosynthetic analysis (Scheme 3) we envisioned that
the C-D synthon 3 would be accessible from the trimethylisoxazolidine 8
which, in turn, would stem from a [3+ 2]-cyc1oaddition with the previously
described C-23 nitrone 4.5 However, in order to control the regiochemistry
and stereochemistry of the olefin cyc1oaddition, 2-methyl-2-butene was not
considered as a satisfactory substr ate. Thermodynamic control of the 1,3-
-dipolar cyc1oaddition dictated the use of a suitable acrylate ester. To this
end, methyl ~,~-dimethylacrylate was chosen as the dipolarophile which would






















produce, with predictable regiochemistry", 5 and furnish the complete carbon
skeleton of the side chain. The C-24 ester group would serve as the progenitor
of the methyl function. Elimination of the nitrogen function would lead to the
!J.22 double bond.
Execution of this approach proceeded without incident. The Z-nitrone 45
underwent a smooth cycloaddition with methyl ~,~-dimethylacrylate8 (Scheme
4) under equilibrating conditions (overnight at 150°C in xylenes) to give es-
Scheme 4 COOM.
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sentialy only two readily separable adducts, 23S,24S ester 5rJ.9 (410/0 yield)
and 23R,24R ester 5b (400/0 yield).
The structure of 5a was established as 23S,24S by X-ray crystallographic
analysis (Figure 1). The structure of the 23R,24R ester 5b was deduced from
the very similar NMR spectrum.!"
Figure 1. A perspective drawing of 5a.
The regiochemistry was as expected. High stereoselectivity, the result of almost
exclusive endo addition to the Z-nitrone5, can be rationalized from a compa-
rison of the endo and exo transition states (Figure 2). Steric hindrance between
C-23 and C-24 substituents in the exo transition state is much more severe
and, consequently, this mode of addition is unfavorable.
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Figure 2.
On the other hand, although no diastereofacial selectivity is achieved,
the product distribution can be controlled. Thus, by a process of separation
of the two isomers (medium pressure LC, silica gel, CH2Clz-EtOAc, 3: 1), and
re-equilibration of the 23R,24R-isomer 5b, (160"C, DMF with excess methyl
B,B-dimethylacrylate, 17 h), it was possible to effectively increase the produc-
tion of the 23S,24S-isomer 5a.
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Conversion of the ester group to the C-24 methyl group (Scheme 5) was
accomplished by the lithium aluminum hydride reduction to alcohol 6 (9011/0
yield), which on treatment with tosyl chloride in pyridine for 48 hrs at room
temperature, gave the 28-monotosylate 7 (90010 yield). The low reactivity of
the axial 8-hydroxyl function made it unnecessary to protect this group during
the entire side chain synthesis. Reduction of the tosylate (LAH, THF, reflux)












-----;;. 3 a ~ 3 b ----?>
10
Excession of the nitrogen function was achieved by c1eavage of the iso-
xazolidine ring (1. MEI, 2. Zn!aq. HOAc) to give aminodio19 (89010 yield)
followed by a Hofmann degradation (1. MeI, 2. t-BuOK!t-BuOH, reflux, 5 hr),
which regiospecifically afforded the trans Li22-diol10 (78% yield). The trans-
-double bond was indicated by NMR, which showed a multiplet at O 5.32 with
J = 16 Hz for the C22-C23 proton coupling, and was unequivocably confirmed
by the X-ray crystallographic analysis (Figure 3).
The secondary C-8 alcohol was oxidized (pyridinium chlorochromate,
methylene chloride, room temperature, 3 hrs) to hydroxyketone 3a (930/0
yield), which was converted to the silyl ether 3b (N-trimethylsilylimidazole,
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Figure 3. A perspective drawing of 10.
84'010 yield). Coupling of the CD ketone 3b and the phosphine oxide 2 anion
under the usual conditions" followed by deprotection (tetrabutylammonium
fluoride, THF, r. t., 23h) gave, in 800/0 yield, crystalline la,25-dihydroxyergo-
calciferol 1. The mass spectrum was in agreement with the reported data."
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The structures of the two crystalline products 5ai and 5bi were established by
X-ray.
11. A. D. Batcho, J. Sereno, N. K. Chadha, J. J. Partridge, E. G.
Bag g i o I i n i, and M. R. U s k o k o v i ć, Current Trends in Organic Synthe-
sis, p. 193, Ed., H. N oza k i, Pergamon Press, New York, 1983.
IZVOD
Stereo-kontro'lisana totalna sinteza la,25-dihidroksi-ergokalciferola
Andrew D. Batcho, John F. Sereno, Enrico G. Baggiolini, Bernard M. Hennessy
i Milan R. Uskoković
Opisana je stereohemijski kontrolisana totalna sinteza metabolita vitamina D2,
1a,25-dihidroksi-ergokalciferola (1), koja se sastoji u kuplovanju ranije opisanog
sintrona prstena A 2 i podesno funkcionalisanog C-D dela molekula 3. U ključno]
fazi, stereohemijska kontrola postignuta je korišćenjem termičke reverzibilnosti
[3 + 2]-cikloadicije metll-Bji-dtmetil-akrilata i C-D C-23 nitrona 4; postali metil-
-estar C-24S-izoksazolidin-karbonske kiseline 5a, redukcijom a zatim eliminacijom
nitronske funkcije, lako se transformiše u željeni C-D prekusor,
